With a landmark patent defeat, Western drug makers will be wary about launching new products in India, but they cannot afford to quit a country slated to be the world's eighth largest medicines market by 2016.

Analysis article by Ben Hirschler and Kaustubh Kulkarni.

Embedded Link

Analysis: Big Pharma down, not out, after Indian patent blow
LONDON/MUMBAI (Reuters) – Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world’s ei…

Google+: View post on Google+

Tags:

Comments are closed.